Helicobacter
April 2018
Background: Recent studies of Lactobacillus delbrueckii subsp. bulgaricus GLB44 plus a proton-pump inhibitor (PPI) reported cures of more than 90% of patients with active Helicobacter pylori infections.Aim: To confirm the high H.
© LitMetric 2025. All rights reserved.